MSK Investigators Report Sialic Acid Test 95% Accurate; Negative Immunotherapy Results Told
In Brief: House, Senate Authorization Measuring Waiting Floor Action; Money Bill Markups Pending
Breast Cancer A Heterogeneous Disease, Concepts Changing: Fisher
Manipulating The Therapeutic Index Clinical Trials Goal: Hellman
NCA Uneasy Over Possible NIH Takeover Of FCRC, But It Won’t Happen
HHS Carcinogen Guidelines Draft
Trending Stories
- The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo
- Senators slam Bhattacharya for deflecting responsibility for NIH cuts, upheaval
Susan Collins: Trump’s 40% cut is “so disturbing” - Insights from ASCO 2025: Real-world evidence drives clinical decision-making
- In the Headlines: Missing record of NCAB meetings restored to NIH website
- The Directors: Candace Johnson and Jonathan Friedberg on living through uncertainty at NCI, payment woes
Directors of two neighboring cancer centers in Upstate New York will face challenges, but “we’ll get through it” - In first NCAB meeting since Trump’s inauguration, Lowy reflects on funding choices in lean times
“In the NCI director’s office, we have a photograph of a stone bridge, and it asks the question, which stone holds up the bridge? And the answer is all of them.”
